Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,865
archived clinical trials in
Multiple Sclerosis

Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated:  3/20/2018
Providence Multiple Sclerosis Center
mi
from
Portland, OR
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated: 3/20/2018
Providence Multiple Sclerosis Center
mi
from
Portland, OR
Click here to add this to my saved trials
Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Status: Enrolling
Updated:  3/20/2018
Multiple Sclerosis Center of Northeastern New York
mi
from
Latham, NY
Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Status: Enrolling
Updated: 3/20/2018
Multiple Sclerosis Center of Northeastern New York
mi
from
Latham, NY
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Breastlink Med Group Inc
mi
from
Long Beach, CA
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Breastlink Med Group Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Multiple Sclerosis Center at UCSF
mi
from
San Francisco, CA
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Multiple Sclerosis Center at UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Raleigh Neurology Associates
mi
from
Raleigh, NC
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Neurology and Neuroscience Associates
mi
from
Akron, OH
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Neurology and Neuroscience Associates
mi
from
Akron, OH
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Hope Neurology MS Center
mi
from
Knoxville, TN
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Hope Neurology MS Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  3/26/2018
Central Texas Neurology Consultants, P.A.
mi
from
Round Rock, TX
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 3/26/2018
Central Texas Neurology Consultants, P.A.
mi
from
Round Rock, TX
Click here to add this to my saved trials
Enhance Wellness for Individuals With Long-Term Physical Disabilities
Project Enhance for Adults Aging With Long-Term Physical Disability
Status: Enrolling
Updated:  3/30/2018
Univ of Washington
mi
from
Seattle, WA
Enhance Wellness for Individuals With Long-Term Physical Disabilities
Project Enhance for Adults Aging With Long-Term Physical Disability
Status: Enrolling
Updated: 3/30/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
Status: Enrolling
Updated:  4/5/2018
Oregon Health and Sciences University
mi
from
Portland, OR
Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
Status: Enrolling
Updated: 4/5/2018
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Mindfulness-based Stress Reduction for Multiple Sclerosis
Status: Enrolling
Updated:  4/6/2018
National College of Natural Medicine
mi
from
Portland, OR
Mindfulness-based Stress Reduction for Multiple Sclerosis
Status: Enrolling
Updated: 4/6/2018
National College of Natural Medicine
mi
from
Portland, OR
Click here to add this to my saved trials
Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
Using OCT to Capture Retinal Microvascular Changes Associated With MS
Status: Enrolling
Updated:  4/10/2018
Oregon Health and Science University
mi
from
Portland, OR
Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
Using OCT to Capture Retinal Microvascular Changes Associated With MS
Status: Enrolling
Updated: 4/10/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
An Open Label Pilot Study of Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event: Comparison With CHAMPS Results.
Status: Enrolling
Updated:  4/10/2018
MidAmerica Neuroscience Institute
mi
from
Kansas City, MO
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
An Open Label Pilot Study of Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event: Comparison With CHAMPS Results.
Status: Enrolling
Updated: 4/10/2018
MidAmerica Neuroscience Institute
mi
from
Kansas City, MO
Click here to add this to my saved trials
Strength Training to Improve Gait in People With Multiple Sclerosis
Targeted Strength Training to Improve Gait in People With Multiple Sclerosis: a Feasibility Study
Status: Enrolling
Updated:  4/11/2018
University of Colorado Denver
mi
from
Aurora, CO
Strength Training to Improve Gait in People With Multiple Sclerosis
Targeted Strength Training to Improve Gait in People With Multiple Sclerosis: a Feasibility Study
Status: Enrolling
Updated: 4/11/2018
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS
A Non-randomized, Exploratory, Study to Assess Clinical Response to Gilenya® (Fingolimod) in a Cohort of Relapsing Remitting Hispanic MS Forms
Status: Enrolling
Updated:  4/30/2018
Keck School of Medicine of the University of Southern Calfornia
mi
from
Los Angeles, CA
Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS
A Non-randomized, Exploratory, Study to Assess Clinical Response to Gilenya® (Fingolimod) in a Cohort of Relapsing Remitting Hispanic MS Forms
Status: Enrolling
Updated: 4/30/2018
Keck School of Medicine of the University of Southern Calfornia
mi
from
Los Angeles, CA
Click here to add this to my saved trials